Fundraising FoxPhase Two Ventures — Full Portfolio
17 tracked investments · listed companies and verified rows first
Acurion Health develops OncoGaze, a technology that predicts clinically actionable genomic biomarkers from routine digital histology tissue slides at the biopsy stage.
AI & Machine LearningBiotechHealthtech
Andson Biotech develops analytical tools for the analysis of biotherapeutics, aimed at supporting the discovery and development of biologic drugs.
BiotechDeep TechHealthtechAtlanta, US
Mason Chilmonczyk(Founder)inJim Filippini(Executive Officer)inRob Grier(Vice President of Operations)
BoardAndrei Fedorov(Director)Thomas O'Brien(Director)James Ross(Director)
Co-investorsGaingelsY CombinatorEquity Trust CompanyMcKesson VenturesMerck Global Health Innovation FundNorthpond Ventures+1 more
__Twitter.png)
Arima Genomics develops DNA-based cancer diagnostics that combine genomic sequence with 3D genome structural information (via Hi-C sequencing) to detect fusions, rearrangements, ecDNA, and other structural drivers of cancer.
BiotechHealthtechMedical Devices
Sid Selvaraj(Founder & Chief Operating Officer)inTom Willis(Chief Executive Officer)inAnthony Schmitt(Senior Vice President, Science)inErin Davis(Vice President, Marketing)in
Co-investorsBerkeley CatalystIllumina Ventures
Defined Bioscience develops cell culture media, growth factors, and related reagents for stem cell biology and regenerative medicine research.
BiotechDeep TechHealthtechMedical DevicesNew Materials
Steve Rees(Co-Founder, CEO)Jerome Karpiak(Co-Founder, VP of R&D)Jose M. Morachis(Founder and Board Chairman)Will Alaynick(Founder and Board Member)
Exthymic is a company working on cell therapy manufacturing, aiming to make cancer cell therapies more accessible to patients who currently cannot obtain them.
BiotechHealthtechSan Diego, US
Rich Stoner(Founder)inDan Knudsen(Founder)Kevin Cooksy(Founder)in
Co-investorsHAWKTAILKdT Ventures
Automated platform for hydrogel testing across medicine, cosmetics, and agriculture applications.
Co-investorsNextFab VenturesTreeo VC
LynxBio (Lynx Biosciences) is a biotech company developing immuno-oncology and immunology therapies using a proprietary patient-based ex vivo disease biology platform combined with a multiomics approach for drug discovery.
AI & Machine LearningBiotechDeep TechSan Diego, US
Chorom Pak(Founder)in
Co-investorsCheckmate Capital Group LLCCove FundGreat Oaks Venture CapitalNuFund Venture GroupFlare Capital Partners
Developer of microfluidic cell sorting technologies for the biotech industry.
BiotechHardwareMedical DevicesSan Diego, US
Jose Morachis(Executive Officer, Director)inNate Heintzman(Executive Officer, Director)inWilliam Alaynick(Executive Officer, Director)Chris Neary(CEO)in
BoardKenneth Hood(Director)
Co-investorsVertical Venture PartnersWarburg PincusAnzu PartnersFusionX VenturesHemisphere Ventures LLCIllumina Ventures+1 more
Navega Therapeutics develops gene therapies using zinc-finger and CRISPR-based epigenome regulation to control gene expression.
BiotechDeep TechHealthtechSan Diego, US
Fernando Aleman(Executive Officer, Director)inAna Moreno(Executive Officer, Director)inRandy Socol(Executive Officer)
Novoron develops lipoprotein-receptor small molecule therapies aimed at repairing damage and degeneration of the brain and spinal cord, including treatments for proteinopathies and neuroregeneration following traumatic injury.
BiotechDeep TechHealthtechMedical DevicesSan Diego, US
Travis Stiles(CEO & Co-founder)inShawn Gahr(COO & Co-founder)inDavid Weiner(Executive Chairman)Ryan McMillian(CFO & Financial Strategy)
BoardMichael Goguen(Director)in
Co-investorsTwo Bear CapitalBackstage Capital
Potato builds software that bridges scientific research and laboratory execution, enabling research teams to move from hypothesis to experiment to learning faster by automating the manual processes between scientific intent and real-world lab work.
AI & Machine LearningBiotechDeep TechSaaS
Merrit Savener(VP of Commercial)
Co-investorsAlumni VenturesDolby Family VenturesDraper AssociatesRoble VenturesEnsemble VC
RyboDyn develops breakthrough immunotherapies by identifying and targeting previously hidden disease markers through its proprietary RyboCypher™ technology platform.
AI & Machine LearningBiotechDeep TechHealthtech
Imad Ajjawi(Co-Founder & Chief Executive Officer)inCorey Dambacher(Founder, President, & Chief Technology Officer)inKerry Wilson(Co-Founder & VP, Platform Development)inAshley Woodfin(Co-Founder & Bioinformatics Lead - Target Discovery)in
Co-investorsSOSVSwell PartnersHOF Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Augment BiologicsMesa BiotechMorphos BioscienceScholarNexusSweetspot Diabetes
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.